Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.
about
Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Co-morbid conditions in use of ...... ent of acute ischaemic stroke.
@en
Co-morbid conditions in use of recombinant tissue plasminogen activator
@nl
type
label
Co-morbid conditions in use of ...... ent of acute ischaemic stroke.
@en
Co-morbid conditions in use of recombinant tissue plasminogen activator
@nl
prefLabel
Co-morbid conditions in use of ...... ent of acute ischaemic stroke.
@en
Co-morbid conditions in use of recombinant tissue plasminogen activator
@nl
P2093
P2860
P1433
P1476
Co-morbid conditions in use of ...... ent of acute ischaemic stroke.
@en
P2093
Alfred Nelson
Crystal Sosa
Dawn Blackhurst
Eric Fulmer
Jose Chaves
Megan Fredwall
Rodney Leacock
Shannon Sternberg
Thomas Cochran
P2860
P304
P356
10.1080/02699052.2016.1186840
P577
2016-08-02T00:00:00Z